Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation-Reference-Cited by-同舟云学术

Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation

Published:2021-11 Issue:3 Volume:111 Page:794-803
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Yokota Tomoya^ORCID,Zenda Sadamoto,Ota Ichiro,Yamazaki Tomoko,Yamaguchi Takuhiro,Ogawa Takenori,Tachibana Hiroyuki,Toshiyasu Takashi,Homma Akihiro,Miyaji Tempei,Mashiko Tomoe,Hamauchi Satoshi,Tominaga Kuniko,Ishii Shinobu,Otani Yui,Orito Noriko,Uchitomi Yosuke

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer;Forastiere;N Engl J Med,2003

2. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

3. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck;Cooper;N Engl J Med,2004

4. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501);Bernier;Head Neck,2005

5. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer;Bernier;N Engl J Med,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective;Cancers;2024-07-12

2. Development of a risk prediction model for radiation dermatitis following proton radiotherapy in head and neck cancer using ensemble machine learning;Radiation Oncology;2024-06-24

3. Comparison of the efficacy among different interventions for radiodermatitis: A Bayesian network meta‑analysis of randomized controlled trials;PLOS ONE;2024-04-10

4. Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures;Clinical and Translational Oncology;2024-04-09

5. Evolution of radiation-induced dermatitis treatment;Clinical and Translational Oncology;2024-04-09